Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

544 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cell clusters adopt a collective amoeboid mode of migration in confined nonadhesive environments.
Pagès DL, Dornier E, de Seze J, Gontran E, Maitra A, Maciejewski A, Wang L, Luan R, Cartry J, Canet-Jourdan C, Raingeaud J, Lemahieu G, Lebel M, Ducreux M, Gelli M, Scoazec JY, Coppey M, Voituriez R, Piel M, Jaulin F. Pagès DL, et al. Among authors: ducreux m. Sci Adv. 2022 Sep 30;8(39):eabp8416. doi: 10.1126/sciadv.abp8416. Epub 2022 Sep 30. Sci Adv. 2022. PMID: 36179021 Free PMC article.
Intervention in gastro-enteropancreatic neuroendocrine tumours.
Baudin E, Planchard D, Scoazec JY, Guigay J, Dromain C, Hadoux J, Debaere T, Elias D, Ducreux M. Baudin E, et al. Among authors: ducreux m. Best Pract Res Clin Gastroenterol. 2012 Dec;26(6):855-65. doi: 10.1016/j.bpg.2013.01.008. Best Pract Res Clin Gastroenterol. 2012. PMID: 23582924 Review.
Not All Patients with a Pancreatic Neuroendocrine Tumour Will Benefit from All Approved or Recommended Therapeutic Options: A Real-Life Retrospective Study.
Berdelou A, Boige V, Arfi-Rouche J, Malka D, Ederhy S, Izzedine H, Leboulleux S, Chougnet CN, Burtin P, De Baere T, Laplanche A, Elias D, Schlumberger M, Scoazec JY, Ducreux M, Baudin E. Berdelou A, et al. Among authors: ducreux m. Neuroendocrinology. 2017;105(1):26-34. doi: 10.1159/000446988. Epub 2016 May 26. Neuroendocrinology. 2017. PMID: 27225439 Free article.
Organoids as preclinical models to improve intraperitoneal chemotherapy effectiveness for colorectal cancer patients with peritoneal metastases: Preclinical models to improve HIPEC.
Roy P, Canet-Jourdan C, Annereau M, Zajac O, Gelli M, Broutin S, Mercier L, Paci A, Lemare F, Ducreux M, Elias D, Malka D, Boige V, Goéré D, Jaulin F. Roy P, et al. Among authors: ducreux m. Int J Pharm. 2017 Oct 5;531(1):143-152. doi: 10.1016/j.ijpharm.2017.07.084. Epub 2017 Aug 11. Int J Pharm. 2017. PMID: 28803938
Tumour spheres with inverted polarity drive the formation of peritoneal metastases in patients with hypermethylated colorectal carcinomas.
Zajac O, Raingeaud J, Libanje F, Lefebvre C, Sabino D, Martins I, Roy P, Benatar C, Canet-Jourdan C, Azorin P, Polrot M, Gonin P, Benbarche S, Souquere S, Pierron G, Nowak D, Bigot L, Ducreux M, Malka D, Lobry C, Scoazec JY, Eveno C, Pocard M, Perfettini JL, Elias D, Dartigues P, Goéré D, Jaulin F. Zajac O, et al. Among authors: ducreux m. Nat Cell Biol. 2018 Mar;20(3):296-306. doi: 10.1038/s41556-017-0027-6. Epub 2018 Feb 5. Nat Cell Biol. 2018. PMID: 29403038
Characterization, Prognosis, and Treatment of Patients With Metastatic Lung Carcinoid Tumors.
Robelin P, Hadoux J, Forestier J, Planchard D, Hervieu V, Berdelou A, Scoazec JY, Valette PJ, Leboulleux S, Ducreux M, Lombard-Bohas C, Baudin E, Walter T. Robelin P, et al. Among authors: ducreux m. J Thorac Oncol. 2019 Jun;14(6):993-1002. doi: 10.1016/j.jtho.2019.02.002. Epub 2019 Feb 13. J Thorac Oncol. 2019. PMID: 30771520 Free article. Review.
Molecular targeted therapy of BRAF-mutant colorectal cancer.
Ducreux M, Chamseddine A, Laurent-Puig P, Smolenschi C, Hollebecque A, Dartigues P, Samallin E, Boige V, Malka D, Gelli M. Ducreux M, et al. Ther Adv Med Oncol. 2019 Jun 18;11:1758835919856494. doi: 10.1177/1758835919856494. eCollection 2019. Ther Adv Med Oncol. 2019. PMID: 31244912 Free PMC article. Review.
Post-Radiation Grade 3 Neuroendocrine Carcinoma: A New Entity?
Hadoux J, Blanchard P, Scoazec JY, Burtin P, Planchard D, Malka D, Berdelou A, Boige V, Duvillard P, Leboulleux S, Faron M, Tselikas L, Deutsch E, Ducreux M, Baudin E. Hadoux J, et al. Among authors: ducreux m. Neuroendocrinology. 2021;111(1-2):139-145. doi: 10.1159/000504255. Epub 2019 Oct 22. Neuroendocrinology. 2021. PMID: 31639792
Prognostic factors of metastatic neuroendocrine carcinoma under first-line treatment with platinum etoposide with a focus on NEC score and Rb expression: Results from the multicentre RBNEC study of the Groupe d'Etude des Tumeurs Endocrines (GTE) and the ENDOCAN-RENATEN network.
Hadoux J, Kanaan C, Durand A, Hescot S, Hautefeuille V, Cadiot G, Tauveron I, Laboureau S, Do Cao C, Walter T, Petorin C, Blanchet O, Jannin A, Gu C, Faron M, Leteurtre E, Rousselet MC, Zakeyh JJ, Marchal A, Chatelain D, Beaulaton C, Hervieu V, Ducreux M, Scoazec JY, Baudin E. Hadoux J, et al. Among authors: ducreux m. Eur J Cancer. 2021 Jul;152:100-115. doi: 10.1016/j.ejca.2021.04.030. Epub 2021 Jun 3. Eur J Cancer. 2021. PMID: 34090142
544 results